Loading issuer details...
Held by NZ managed funds
Sub-substantial fund positions — invisible in NZX SSH data, visible here. Sourced from each fund's Quarterly Fund Update on the FMA Disclose register.
| Fund | % of fund NAV |
|---|---|
| Mint — New Zealand Sri Equity | 6.62% |
| Mint — Australasian Equity | 6.50% |
| Fisher Funds — New Zealand Growth | 5.72% |
| Harbour — Sustainable NZ Shares | 5.21% |
| Harbour — NZ Index Shares | 5.07% |
+ 5 more funds hold EBO. Full breakdown and coverage
How EBOS Group Limited makes money — FY2025
Revenue $12.3b · EBITDA $555.6m (4.5% of revenue) · Net profit $215.8m (1.8% of revenue) · Balance date 30 June 2025
Band widths are proportional to NZD amounts. Dashed outlines mark derived figures; the hatched node is a balancing item (net profit less every line above it).
| FY2025 | Amount | Status | Note |
|---|---|---|---|
| Revenue | $12.3b | Reported | |
| Operating costs (net of other income) | −$11.7b | Derived * | |
| EBITDA | $555.6m | Reported | |
| Depreciation & amortisation | −$146.9m | Reported | |
| EBIT | $408.7m | Reported | |
| Interest (net finance costs) | −$113.5m | Reported | |
| Income tax | −$86.5m | Reported | |
| Other items (net gain) | +$7.1m | Balancing item * | Net profit less the lines above; covers fair-value movements, impairments, associates and anything else not itemised. |
| Net profit | $215.8m | Reported |
- * operating costs: $11.7b = Revenue − EBITDA
Figures extracted automatically from the annual report; check against the report. NZD thousands as stored, shown in millions. Source: annual_report_pdf · method: claude_haiku_pdf · extracted 7 March 2026.
Annual report: EBOS Group Limited Annual Report (PDF, NZX)
EBOS Group Limited board of directors
7 current directors, 86% independent, average tenure 6.8 years.
| Director | Role | Independent | Appointed | Tenure | Committees |
|---|---|---|---|---|---|
| Elizabeth Coutts | Chair | Yes | 2003 | 23.4 yrs | Audit & Risk, Remuneration |
| Julie Tay | Independent Director | Yes | 2023 | 3.5 yrs | — |
| Matthew Muscio | Non-Independent Director | No | 2025 | 1.9 yrs | — |
| Tracey Batten | Independent Director | Yes | 2021 | 5.4 yrs | Remuneration |
| Mark Bloom | Independent Director | Yes | 2022 | 4.2 yrs | Audit & Risk |
| Coline McConville | Independent Director | Yes | 2025 | 1.8 yrs | Audit & Risk Committee (Chair), Remuneration Committee |
| Stuart McLauchlan | Independent Director | Yes | 2019 | 7.4 yrs | Audit & Risk (Chair), Remuneration |
EBO governance score breakdown
EBOS Group Limited scores 83/100 (Excellent) on the NZXplorer Governance Risk Score for FY2026, based on 73% data coverage. See the GRS methodology.
- Board structure
- 25/25
- Shareholder rights
- 20/20
- Executive remuneration
- 1/10
EBO dividends
The most recent EBOS Group Limited dividend on record is 61.50 cents per share, for FY2026 (final), 20% imputed, ex-dividend 27 Aug 2026, paid 18 Sept 2026.
EBOS Group Limited largest shareholders
Top 10 registered holders of EBO as disclosed for FY2025. Registry holdings include custodians and nominees, which may hold on behalf of many underlying investors.
| # | Holder | Holding |
|---|---|---|
| 1 | JP Morgan Nominees Australia Limited | 12.34% |
| 2 | HSBC Nominees (New Zealand) Limited – NZCSD | 7.22% |
| 3 | HSBC Custody Nominees (Australia) Limited | 6.73% |
| 4 | BNP Paribas Nominees (NZ) Limited – NZCSD | 6.64% |
| 5 | Custodial Services Limited | 6.24% |
| 6 | Sybos Holdings PTE Limited | 4.90% |
| 7 | Forsyth Barr Custodians Limited | 4.24% |
| 8 | HSBC Nominees (New Zealand) Limited A/C State Street –NZCSD | 4.19% |
| 9 | Tea Custodians Limited Client Property Trust Account – NZCSD | 4.09% |
| 10 | JPMorgan Chase Bank NA NZ Branch-Segregated Clients Acct – NZCSD | 3.82% |
Recent EBO NZX announcements
The 10 most recent filings by EBOS Group Limited to the NZX.
- Results of MeetingAGM
- Annual Meeting PresentationAGM
- Capital Change Notice - Employee Share PlanCapital Change
- Capital Change NoticesCapital Change
- ASX Appendix 3GsGeneral
- Performance Rights UpdateGeneral
- ASX Form 605General
- Performance Rights UpdateGeneral
- Ongoing Disclosure NoticesInsider Disclosure
- NZX Capital Change NoticeCapital Change
EBOS Group Limited (EBO) — frequently asked questions
What does EBOS Group Limited do?
EBOS Group is a leading Australasian healthcare and animal care company, distributing pharmaceuticals, medical devices, and consumer products through its Healthcare and Animal Care divisions across Australia, New Zealand, and Asia. EBOS Group Limited is listed on the NZX under the ticker EBO, in the Healthcare sector.
What is the EBOS Group Limited (EBO) share price?
EBOS Group Limited (NZX:EBO) shares closed at $21.80 on 12 November 2026, up 1.87% on the previous close. At that price its market capitalisation was about $4.47 billion, based on 205,038,721 shares on issue as at 18 February 2026.
Who are the directors of EBOS Group Limited?
EBOS Group Limited has 7 current directors: Elizabeth Coutts (Chair), Julie Tay (Independent Director), Matthew Muscio (Non-Independent Director), Tracey Batten (Independent Director), Mark Bloom (Independent Director), Coline McConville (Independent Director) and Stuart McLauchlan (Independent Director). 6 of the 7 are recorded as independent (86%). Average board tenure is 6.8 years.
Who is the chair of EBOS Group Limited?
Elizabeth Coutts chairs the EBOS Group Limited board, and has been a director since 2003.
What was EBOS Group Limited's most recent dividend?
The most recent EBOS Group Limited dividend on record is 61.50 cents per share for FY2026 (final), 20% imputed, ex-dividend 27 August 2026, paid 18 September 2026.
Who are the largest shareholders of EBOS Group Limited?
The largest registered holder of EBO shares in the FY2025 top-20 register was JP Morgan Nominees Australia Limited, with 12.34%, followed by HSBC Nominees (New Zealand) Limited – NZCSD (7.22%) and HSBC Custody Nominees (Australia) Limited (6.73%). Custodians and nominees on the register hold shares on behalf of other investors.
What is EBOS Group Limited's governance score?
EBOS Group Limited has an NZXplorer Governance Risk Score of 83/100 (Excellent) for FY2026, based on 73% data coverage.
When was the last EBOS Group Limited annual meeting?
The most recent EBOS Group Limited annual meeting on record was held on 21 October 2026.
Healthcare companies on the NZX
Compare EBOS Group Limited with other NZX-listed healthcare companies.